Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soldano Ferrone

Showing results (1-10 of 334) with videos related to

Pageof 34
Sort By:
Science Translational Medicine|September 9, 2011
Hidden immunotherapy targets challenge dogmaSoldano Ferrone
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2020
Improving the Clinical Significance of Preclinical Immunotherapy Studies through Incorporating Tumor Microenvironment-like ConditionsLuke Maggs, Soldano Ferrone
Expert Review of Vaccines|April 2, 2004
T-cell-based immunotherapy of melanoma: what have we learned and how can we improve?Michael Campoli, Soldano Ferrone
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2019
HLA Class I Antigen Processing Machinery Defects in Cancer Cells-Frequency, Functional Significance, and Clinical Relevance with Special Emphasis on Their Role in T Cell-Based Immunotherapy of Malignant DiseaseBarbara Seliger, Soldano Ferrone
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2013
Can the "right" EGFR-specific mAb dramatically improve EGFR-targeted therapy?Francesco Sabbatino, Soldano Ferrone
Seminars in Immunopathology|April 28, 2011
HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisitionMichael Campoli, Soldano Ferrone
Seminars in Cancer Biology|August 26, 2006
NK cell activating ligands on human malignant cells: molecular and functional defects and potential clinical relevanceChien-Chung Chang, Soldano Ferrone
Seminars in Cancer Biology|January 8, 2004
HLA-G in melanoma: can the current controversies be solved?Chien-Chung Chang, Soldano Ferrone
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2012
For breast cancer prognosis, immunoglobulin kappa chain surfaces to the topTheresa L Whiteside, Soldano Ferrone
Cancer Immunology, Immunotherapy : CII|June 20, 2006
Immune selective pressure and HLA class I antigen defects in malignant lesionsChien-Chung Chang, Soldano Ferrone
Pageof 34

Showing results (1-10 of 334) with videos related to

Sort By:
Pageof 34
Science Translational Medicine|September 9, 2011
Hidden immunotherapy targets challenge dogmaSoldano Ferrone
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2020
Improving the Clinical Significance of Preclinical Immunotherapy Studies through Incorporating Tumor Microenvironment-like ConditionsLuke Maggs, Soldano Ferrone
Expert Review of Vaccines|April 2, 2004
T-cell-based immunotherapy of melanoma: what have we learned and how can we improve?Michael Campoli, Soldano Ferrone
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2019
HLA Class I Antigen Processing Machinery Defects in Cancer Cells-Frequency, Functional Significance, and Clinical Relevance with Special Emphasis on Their Role in T Cell-Based Immunotherapy of Malignant DiseaseBarbara Seliger, Soldano Ferrone
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2013
Can the "right" EGFR-specific mAb dramatically improve EGFR-targeted therapy?Francesco Sabbatino, Soldano Ferrone
Seminars in Immunopathology|April 28, 2011
HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisitionMichael Campoli, Soldano Ferrone
Seminars in Cancer Biology|August 26, 2006
NK cell activating ligands on human malignant cells: molecular and functional defects and potential clinical relevanceChien-Chung Chang, Soldano Ferrone
Seminars in Cancer Biology|January 8, 2004
HLA-G in melanoma: can the current controversies be solved?Chien-Chung Chang, Soldano Ferrone
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2012
For breast cancer prognosis, immunoglobulin kappa chain surfaces to the topTheresa L Whiteside, Soldano Ferrone
Cancer Immunology, Immunotherapy : CII|June 20, 2006
Immune selective pressure and HLA class I antigen defects in malignant lesionsChien-Chung Chang, Soldano Ferrone
Pageof 34